Live tape
Top 8, mentions 7d9,514GOOGL1,899 mentions▲ +0.04SNDK1,548 mentions▲ +0.11NVDA1,168 mentions▲ +0.08META1,148 mentions▲ +0.03SPCX1,096 mentions▲ +0.08NBIS984 mentions▲ +0.09HTZ857 mentions▲ +0.09VOO814 mentions▲ +0.09

Equity · Healthcare

CCRN

Cross Country Healthcare, Inc. · NasdaqGS

$13.26 +0.11% 1D Finazon · prior-day close · Jul 20, 2026
Price · Chart
Our own end-of-day closes 40 sessions
$13.3 $13.0 21 May 20 Jul

The line runs $13.07 on 21 May through $13.26 on 20 July, on a scale from $13.0 to $13.3. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of CCRN over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 40 sessions over that window: $13.07 on 21 May 2026 through $13.26 on 20 July 2026.

Market cap $428.6M
52-week range $7.61 – $14.23
Avg volume 212.6K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 19, 2026

CCRN insider trades

SEC Form 4 · last 90 days · newest Form 4 filing 21 Jul 2026
Open-market buys 0
Open-market sells 0
Non-trade filings 18

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
21 Jul 2026 Allen Dwayne Director Other 31,289 $415K
21 Jul 2026 Ball Susan E General Counsel and Secretary Other 314,649 $4.17M
21 Jul 2026 Ball Susan E General Counsel and Secretary Award 72,872
21 Jul 2026 Bhamidipati Venkat Director Other 29,759 $394K
21 Jul 2026 Burns William J. Chief Financial Officer Other 440,595 $5.84M
21 Jul 2026 Burns William J. Chief Financial Officer Award 104,157
21 Jul 2026 CASH W LARRY Director Other 223,312 $2.96M
21 Jul 2026 FITZGERALD GALE S Director Other 194,249 $2.57M
21 Jul 2026 Nevin Janice Elizabeth Director Other 48,616 $644K
21 Jul 2026 Clark Kevin Cronin Chief Executive Officer Other 1,199,510 $15.89M
21 Jul 2026 Clark Kevin Cronin Chief Executive Officer Award 247,416
21 Jul 2026 Krug Marc S. Group President, Delivery Other 124,352 $1.65M

Showing the 12 most recent of 18 compensation filings in this window. The figures above count all of them.

CCRN reported financials

SEC EDGAR XBRL

CCRN reported revenue of $1.1B for the fiscal year ended 31 Dec 2025. Net income over the same period was −$94.9M.

Figure Reported Period
Revenue $1.1B 31 Dec 2025 fiscal year
Net income −$94.9M 31 Dec 2025 fiscal year
Diluted EPS −$2.93 31 Dec 2025 fiscal year
Total assets $451.1M 31 Mar 2026 at period end
Total equity $312.8M 31 Mar 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 31 Mar 2026

CCRN earnings

SEC EDGAR
Date Period EPS Revenue
31 Mar 2026 Q1 2026 $-0.14 —
31 Dec 2025 FY 2025 $-2.56 —
30 Sep 2025 FY 2025 $-0.15 —
30 Jun 2025 FY 2025 $-0.20 —
31 Mar 2025 FY 2025 $-0.02 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

CCRN institutional holders

SEC Form 13F

9 of the 45 institutional funds we track reported a CCRN position for the quarter ended 30 Jun 2026 — a combined $17.5M; the latest of those filings landed 14 Aug 2026.

Fund Action Shares Value
Millennium Management New position 912,378 $12.1M
Renaissance Technologies Trimmed −37.8% shares 152,683 $2.0M
Two Sigma Investments Added +69.8% shares 89,060 $1.2M
GAMCO Investors Added +240.4% shares 80,000 $1.1M
Man Group New position 28,313 $374K
AQR Capital Management Trimmed −53.9% shares 21,261 $281K
Marshall Wace Trimmed −96.3% shares 17,000 $225K
D. E. Shaw & Co. Trimmed −80.0% shares 14,397 $190K
Citadel Advisors Trimmed −96.4% shares 10,942 $145K
Balyasny Asset Management Exited

Source: SEC EDGAR 13F filings

CCRN fails-to-deliver

SEC CNS data

On 22 Jul 2026, 21 shares of CCRN failed to deliver (about $278).

Settlement date Shares failed Notional % of shares out
22 Jul 2026 21 $278 <0.001%

Source: SEC fails-to-deliver (CNS) data